PAK4 and malignant colon neoplasm: ABT-737 (Table 2) is a small-molecule inhibitor that represses Bcl-2/Bcl-XL, resulting in the inhibition of RNAi of PAK4 and PAK1 in HCT116 colon cancer cells [96].